Frontiers in Allergy | Drug, Venom & Anaphylaxis

Brief Research Report

Published on 16 Jan 2024

Feasibility of a drug allergy registry-based excipient allergy database and call for universal mandatory drug ingredient disclosure: the case of PEG

in Drug, Venom & Anaphylaxis

Andy Ka Chun Kan
Valerie Chiang
Chinmoy Saha
Elaine Y. L. Au
Philip Hei Li

Frontiers in Allergy

doi 10.3389/falgy.2023.1331036

1,398 views
1 citation

Correction

Published on 12 Jan 2024

Corrigendum: Approach for delabeling beta-lactam allergy in children

in Drug, Venom & Anaphylaxis

R. Sáenz de Santa María
G. Bogas
M. Labella
A. Ariza
M. Salas
I. Doña
M. J. Torres

Frontiers in Allergy

doi 10.3389/falgy.2023.1361973

1,037 views

Review

Published on 14 Dec 2023

Potential and limitations of epitope mapping and molecular targeting in Hymenoptera venom allergy

in Drug, Venom & Anaphylaxis

Luís Gustavo Romani Fernandes
Edzard Spillner
Thilo Jakob

Frontiers in Allergy

doi 10.3389/falgy.2023.1327391

3,090 views
1 citation

Review

Published on 15 Nov 2023

Approach for delabeling beta-lactam allergy in children

in Drug, Venom & Anaphylaxis

R. Sáenz de Santa María
G. Bogas
M. Labella
A. Ariza
M. Salas
I. Doña
M. J. Torres

Frontiers in Allergy

doi 10.3389/falgy.2023.1298335

3,819 views
5 citations

Editorial

Published on 19 Sep 2023

Editorial: Antibiotic allergy de-labelling and management

in Drug, Venom & Anaphylaxis

Gigia Roizen
Patrick E. Beeler
Miguel Park
Mariana Castells
Elina Jerschow

Frontiers in Allergy

doi 10.3389/falgy.2023.1278690

1,292 views
1 citation

Brief Research Report

Published on 31 Jul 2023

Use of a beta-lactam graded challenge process for inpatients with self-reported penicillin allergies at an academic medical center

in Drug, Venom & Anaphylaxis

Shawnalyn W. Sunagawa
Scott J. Bergman
Emily Kreikemeier
Andrew B. Watkins
Bryan T. Alexander
Molly M. Miller
Danny Schroeder
Erica J. Stohs
Trevor C. Van Schooneveld
Sara M. May

Frontiers in Allergy

doi 10.3389/falgy.2023.1161683

3,699 views
1 citation

Case Report

Published on 27 Jul 2023

Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report

in Drug, Venom & Anaphylaxis

Hassan Mobayed
Maryam Ali Al-Nesf
Karla Robles-Velasco
Ivan Cherrez-Ojeda
Luis Felipe Ensina
Marcus Maurer

Frontiers in Allergy

doi 10.3389/falgy.2023.1228495

2,383 views
3 citations

Editorial

Published on 13 Jul 2023

Editorial: Assessment and management of adverse drug reactions in oncology

in Drug, Venom & Anaphylaxis

Ping-Feng Tsai
Kevin Sheng-Kai Ma

Frontiers in Allergy

doi 10.3389/falgy.2023.1223078

1,733 views

Original Research

Published on 04 Jul 2023

Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles

in Drug, Venom & Anaphylaxis

Hannah S. Newton
Jenny Zhang
Duncan Donohue
Ragi Unnithan
Edward Cedrone
Jie Xu
Alison Vermilya
Tyler Malys
Jeffrey D. Clogston
Marina A. Dobrovolskaia

Frontiers in Allergy

doi 10.3389/falgy.2023.1126012

2,596 views
2 citations

Editorial

Published on 24 May 2023

Editorial: Immune-related adverse Events (irAEs) of biopharmaceuticals

in Drug, Venom & Anaphylaxis

Alexander Batista-Duharte
Salvador F. Aliño

Frontiers in Allergy

doi 10.3389/falgy.2023.1214914

1,460 views

Editorial

Published on 11 May 2023

Editorial: Diagnosis and management of allergy to chemotherapy and biologics

in Drug, Venom & Anaphylaxis

Ricardo Madrigal-Burgaleta
Mariana Castells

Frontiers in Allergy

doi 10.3389/falgy.2023.1205345

2,363 views
2 citations

Case Report

Published on 09 May 2023

Case report: Insulin desensitization as the only option for managing insulin allergy in a Sudanese patient

in Drug, Venom & Anaphylaxis

Rihan Said
Rayan Goda
Ihab B. Abdalrahman
Nahla H. H. Erwa

Frontiers in Allergy

doi 10.3389/falgy.2023.1089966

2,387 views
1 citation

Brief Research Report

Published on 03 May 2023

Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization

in Drug, Venom & Anaphylaxis

Ibtihal AlOtaibi
Faisal Almuhizi
Shaonie Ton-Leclerc
Michael Fein
Christos Tsoukas
Lene Heise Garvey
Derek Lee
Moshe Ben-Shoshan
Ghislaine A. C. Isabwe
Ana M. Copaescu

Frontiers in Allergy

doi 10.3389/falgy.2023.1056619

2,094 views
1 citation

Brief Research Report

Published on 30 Mar 2023

A potential cost savings analysis of a penicillin de-labeling program

in Drug, Venom & Anaphylaxis

Yilu Dong
Tracy N. Zembles
Mark Nimmer
David C. Brousseau
David Vyles

Frontiers in Allergy

doi 10.3389/falgy.2023.1101321

2,171 views
4 citations

Mini Review

Published on 16 Mar 2023

Delabelling multiple antibiotic allergy: Practical issues

in Drug, Venom & Anaphylaxis

Philip Hei Li
Bernard Yu-Hor Thong

Frontiers in Allergy

doi 10.3389/falgy.2023.1156137

4,705 views
3 citations

Mini Review

Published on 02 Mar 2023

Mucocutaneous adverse events to immune checkpoint inhibitors

in Drug, Venom & Anaphylaxis

Fiorinda Muhaj
Padmavathi V. Karri
Wylie Moody
Alexandria Brown
Anisha B. Patel

Frontiers in Allergy

doi 10.3389/falgy.2023.1147513

4,839 views
4 citations